Finally, further in vitro and in vivo molecular biological experiments are needed be performed to demonstrate concrete mechanisms by which METTL21B regulates malignant behaviors of LGG, especially the correlation with eEF1A and tumor immune microenvironment. The gene discussed is EEF1AKMT3; the disease is neoplasm.